AstraZeneca · 6 hours ago
Senior Director, Global Program Team Lead
AstraZeneca is a leading biopharmaceutical company seeking a Senior Director, Global Program Team Lead. The role involves driving drug development programs, providing strategic direction, and leading global teams to ensure effective and efficient development of projects from Post-PoC to commercial approval.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Program ownership with final accountability for clear definitions of program goals, plans, decisions, and deliverables to meet those goals
Provides strategic direction and leadership of global development programs from Post-PoC to BLA/NDA/MAA for assigned projects in accordance with the global R&D strategy
Ensures that the GPT implements its plans and adheres to key development milestones for assigned projects
Accountable for aspects of pre-clinical, CMC, clinical plans and programs across from Post-PoC through commercial approval for assigned projects
Leads the global project team and reviews development plans for assigned projects and thorough product lifecycle management for assigned projects
Contributes to objective setting and appraisal of core team members for program related activities
Keeps senior management informed
Is accountable for the program budget
Ensures high performance team effectiveness
Leads and chairs the Global Program Team (GPT), leading the creation of an integrated development plan, maintaining a strategic focus and ensuring the GPT’s commitments are met
Stimulates creative and productive discussion, motivates, ownership and urgency as well as robust discussions of risk identification and mitigation opportunities
Ensures clarity of purpose and responsibilities with the GPT
Has negotiation and persuasion skills necessary to ensure success of the program and sets goals for the GPT and specific program-related goals for the Core Team members
Acts as the voice of the GPT up the line and is the principal liaison and partner to other groups
Qualification
Required
Science or medical degree (e.g. MD, PhD, PharmD), with specialist training or significant experience in either Haematology or Nephrology
Total leadership experience including line/project management, multidisciplinary program management experience, which includes leadership in more than one IND/IMPS, BLA/NDA/MAA, Advisory Committee or other PMDA/EMA/FDA meetings is desirable
Minimum of ten (10) years of experience in drug development in pharmaceuticals, biopharmaceuticals, biotechnology or equivalent cross-functional leadership experience
Demonstrated experience leading the development of at least one development candidate with adherence to quality, excellence and efficiency
Demonstrated experience leading drug development projects and activities in a matrixed, global organization
A broad understanding of how to communicate and work well with team members and relevant people as well as scientists and external decision-makers worldwide
A thorough understanding of how to influence local and global regulatory, scientific and commercial environments
Ability to assimilate data, recognize key variables and analyze complex situations
Has experience leading preparation of PMDA/EMA/FDA milestone meetings, such as Pre-IND, EoP-1, EoP-2, Pre-BLA/NDA, Advisory Committees, focusing on the key strategic issues
Excellent understanding of the interdependencies of the various disciplines (e.g., CMC, Pharm/Tox, PK, Clinical, Regulatory, Marketing, Finance) – what needs to be evaluated simultaneously vs. sequentially etc. from a strategic planning/risk management time/event/cost point locally and globally
Has a firm understanding of how to educate/advise/operate with respect to Regulatory Guidances/Internal SOPs/Project best-practice behaviours
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-13
2026-01-12
Medical Xpress - latest medical and health news stories
2026-01-12
Company data provided by crunchbase